Identification of a Novel Class of Farnesylation Targets by Structure-Based Modeling of Binding Specificity

Farnesylation is an important post-translational modification catalyzed by farnesyltransferase (FTase). Until recently it was believed that a C-terminal CaaX motif is required for farnesylation, but recent experiments have revealed larger substrate diversity. In this study, we propose a general structural modeling scheme to account for peptide binding specificity and recapitulate the experimentally derived selectivity profile of FTase in vitro. In addition to highly accurate recovery of known FTase targets, we also identify a range of novel potential targets in the human genome, including a new substrate class with an acidic C-terminal residue (CxxD/E). In vitro experiments verified farnesylation of 26/29 tested peptides, including both novel human targets, as well as peptides predicted to tightly bind FTase. This study extends the putative range of biological farnesylation substrates. Moreover, it suggests that the ability of a peptide to bind FTase is a main determinant for the farnesylation reaction. Finally, simple adaptation of our approach can contribute to more accurate and complete elucidation of peptide-mediated interactions and modifications in the cell.

[1]  D. Andres,et al.  Protein farnesyl transferase target selectivity is dependent upon peptide stimulated product release. , 2007, Biochemistry.

[2]  S. Maurer-Stroh,et al.  Protein Prenyltransferases: Anchor Size, Pseudogenes and Parasites , 2003, Biological chemistry.

[3]  L. Beese,et al.  Thematic review series: Lipid Posttranslational Modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I Published, JLR Papers in Press, February 13, 2006. , 2006, Journal of Lipid Research.

[4]  P. Casey,et al.  Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.

[5]  V S Caviness,et al.  The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development. , 2000, Development.

[6]  C J Marshall,et al.  Protein prenylation: a mediator of protein-protein interactions. , 1993, Science.

[7]  A. Schürmann,et al.  Alternative mRNA splicing of the novel GTPase Rab28 generates isoforms with different C-termini. , 1996, European journal of biochemistry.

[8]  Xavier Estivill,et al.  Intersectin 2, a new multimodular protein involved in clathrin‐mediated endocytosis , 2000, FEBS letters.

[9]  Oleksii Nikolaienko,et al.  Intersectin multidomain adaptor proteins: regulation of functional diversity. , 2011, Gene.

[10]  Nicole Cloonan,et al.  Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. , 2007, Cellular signalling.

[11]  J. Colicelli,et al.  Human RAS Superfamily Proteins and Related GTPases , 2004, Science's STKE.

[12]  The UniProt Consortium,et al.  The Universal Protein Resource (UniProt) 2009 , 2008, Nucleic Acids Res..

[13]  S. Sebti,et al.  Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies , 2000, Oncogene.

[14]  R. Rudolph,et al.  Identification of a Disulfide Bridge Essential for Transport Function of the Human Proton-coupled Amino Acid Transporter hPAT1* , 2009, The Journal of Biological Chemistry.

[15]  A. Cox,et al.  Farnesyltransferase inhibitors: potential role in the treatment of cancer. , 2001, Drugs.

[16]  P. Casey,et al.  Enzymology and biology of CaaX protein prenylation. , 1999, Recent progress in hormone research.

[17]  Pradeep Kota,et al.  Identification of a consensus motif in substrates bound by a Type I Hsp40 , 2009, Proceedings of the National Academy of Sciences.

[18]  D P Siderovski,et al.  Quantitative Analysis of the Effect of Phosphoinositide Interactions on the Function of Dbl Family Proteins* , 2001, The Journal of Biological Chemistry.

[19]  Maria João Ramos,et al.  Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem. , 2008, Current medicinal chemistry.

[20]  C. Fierke,et al.  Upstream polybasic region in peptides enhances dual specificity for prenylation by both farnesyltransferase and geranylgeranyltransferase type I. , 2005, Biochemistry.

[21]  M. Šantić,et al.  Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila , 2010, The Journal of experimental medicine.

[22]  Elisabeth L. Humphris,et al.  Prediction of protein-protein interface sequence diversity using flexible backbone computational protein design. , 2008, Structure.

[23]  Jens Meiler,et al.  A physical model for PDZ-domain/peptide interactions , 2010, Journal of molecular modeling.

[24]  Saïd M. Sebti,et al.  Searching for the elusive targets of farnesyltransferase inhibitors , 2003, Nature Reviews Cancer.

[25]  Nir London,et al.  Sub‐angstrom modeling of complexes between flexible peptides and globular proteins , 2010, Proteins.

[26]  G. Charron,et al.  Lipidation by the Host Prenyltransferase Machinery Facilitates Membrane Localization of Legionella pneumophila Effector Proteins* , 2010, The Journal of Biological Chemistry.

[27]  P. Casey,et al.  Substrate Binding Is Required for Release of Product from Mammalian Protein Farnesyltransferase* , 1997, The Journal of Biological Chemistry.

[28]  Colin A. Smith,et al.  Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction. , 2008, Journal of molecular biology.

[29]  F. Eisenhaber,et al.  Refinement and prediction of protein prenylation motifs , 2005, Genome Biology.

[30]  David Baker,et al.  Protein Structure Prediction Using Rosetta , 2004, Numerical Computer Methods, Part D.

[31]  James R. Apgar,et al.  Modeling backbone flexibility to achieve sequence diversity: the design of novel alpha-helical ligands for Bcl-xL. , 2007, Journal of molecular biology.

[32]  K. Siminovitch,et al.  The Intersectin 2 Adaptor Links Wiskott Aldrich Syndrome Protein (WASp)-mediated Actin Polymerization to T Cell Antigen Receptor Endocytosis , 2001, The Journal of experimental medicine.

[33]  Y. Kwaik,et al.  Host-Mediated Post-Translational Prenylation of Novel Dot/Icm-Translocated Effectors of Legionella Pneumophila , 2010, Front. Microbio..

[34]  Tanja Kortemme,et al.  Backbone flexibility in computational protein design. , 2009, Current opinion in biotechnology.

[35]  E. Birney,et al.  The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.

[36]  A. Ridley Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. , 2006, Trends in cell biology.

[37]  Corissa L. Lamphear,et al.  Context-dependent substrate recognition by protein farnesyltransferase. , 2009, Biochemistry.

[38]  C. Fierke,et al.  Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase. , 2006, Journal of the American Chemical Society.

[39]  D. Baker,et al.  Native protein sequences are close to optimal for their structures. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Südhof,et al.  C2-domains, Structure and Function of a Universal Ca2+-binding Domain* , 1998, The Journal of Biological Chemistry.

[41]  David K Williams,et al.  Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. , 2005, Journal of medicinal chemistry.

[42]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[43]  F. Tamanoi,et al.  A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Yoichi Matsuda,et al.  Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation , 2004, Oncogene.

[45]  Kai Simons,et al.  Greasing their way: lipid modifications determine protein association with membrane rafts. , 2010, Biochemistry.

[46]  R. Russell,et al.  Peptide-mediated interactions in biological systems: new discoveries and applications. , 2008, Current opinion in biotechnology.

[47]  P. Casey,et al.  Conversion of protein farnesyltransferase to a geranylgeranyltransferase. , 2006, Biochemistry.

[48]  P. Casey,et al.  Lipid modifications of G proteins. , 1994, Current opinion in cell biology.

[49]  Sebastian Maurer-Stroh,et al.  Protein prenyltransferases , 2003, Genome Biology.

[50]  Stephen B. Long,et al.  Reaction path of protein farnesyltransferase at atomic resolution , 2002, Nature.

[51]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[52]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[53]  Richard T Eastman,et al.  Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis. , 2005, Current opinion in investigational drugs.

[54]  P. Casey,et al.  Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation. , 2003, Biochemistry.

[55]  Fernanda L. Sirota,et al.  Towards Complete Sets of Farnesylated and Geranylgeranylated Proteins , 2007, PLoS Comput. Biol..

[56]  David Baker,et al.  Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.

[57]  Jeffrey J. Gray,et al.  Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance. , 2009, Structure.

[58]  A. R. Fresht Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding , 1999 .

[59]  James L. Hougland,et al.  Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates. , 2010, Bioorganic & medicinal chemistry letters.

[60]  P. Casey,et al.  Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. , 2004, Journal of molecular biology.

[61]  James L. Hougland,et al.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities. , 2010, Journal of molecular biology.

[62]  Gevorg Grigoryan,et al.  Design of protein-interaction specificity affords selective bZIP-binding peptides , 2009, Nature.

[63]  Andrea K. Stoddard,et al.  A continuous fluorescent assay for protein prenyltransferases measuring diphosphate release. , 2005, Analytical biochemistry.